Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Change in Receivables (2020 - 2025)

Historic Change in Receivables for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $6.4 million.

  • Sotera Health's Change in Receivables rose 679.51% to $6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.4 million, marking a year-over-year increase of 9657.68%. This contributed to the annual value of -$2.2 million for FY2024, which is 11020.07% down from last year.
  • As of Q3 2025, Sotera Health's Change in Receivables stood at $6.4 million, which was up 679.51% from $4.5 million recorded in Q2 2025.
  • Sotera Health's Change in Receivables' 5-year high stood at $22.0 million during Q4 2023, with a 5-year trough of -$40.6 million in Q1 2024.
  • For the 5-year period, Sotera Health's Change in Receivables averaged around $2.4 million, with its median value being $6.0 million (2024).
  • As far as peak fluctuations go, Sotera Health's Change in Receivables skyrocketed by 85473.44% in 2021, and later crashed by 29684.05% in 2024.
  • Quarter analysis of 5 years shows Sotera Health's Change in Receivables stood at $10.6 million in 2021, then crashed by 62.32% to $4.0 million in 2022, then soared by 451.06% to $22.0 million in 2023, then tumbled by 36.32% to $14.0 million in 2024, then plummeted by 54.17% to $6.4 million in 2025.
  • Its Change in Receivables stands at $6.4 million for Q3 2025, versus $4.5 million for Q2 2025 and -$13.6 million for Q1 2025.